Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe
NeoRisk
1 other identifier
observational
2,500
2 countries
2
Brief Summary
The goal of this observational study is to develop a risk prediction model for early-onset neonatal sepsis in term and late preterm neonates in Uganda and Zimbabwe. The main questions it aims to answer are:
- What are the risk factors for early-onset neonatal sepsis in low-resource settings?
- How can these be combined into a risk prediction model? Mother-baby pairs will be recruited in Uganda. They will have extensive data taken on their medical and obstetric histories and lifestyles, and their newborns will have a blood sample taken just after birth for culture. Machine learning techniques will be used to create the risk prediction model, which will then be validated in a second population in Zimbabwe.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2024
CompletedFirst Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMay 17, 2024
February 1, 2024
9 months
April 17, 2024
May 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Positive blood culture amongst neonatal participants
Venous blood culture processed on BACTEC machine
Sample taken in first 48 hours of life
Secondary Outcomes (5)
Documented clinical diagnosis of sepsis amongst neonatal participants
Within first 72 hours of life
Clinical features of neonatal sepsis
Within first 72 hours of life
Admission to neonatal unit
Within first 72 hours of life
Readmission to hospital in first 28 days amongst neonatal participants
Within 28 days of birth
Death before 28 days of age
Within 28 days of birth
Study Arms (2)
Ugandan mother-baby cohort
Mother-baby pairs recruited antenatally or at delivery, with babies eligible for inclusion if they are born at 34 weeks gestational age and above. Used as primary data for modelling.
Zimbabwean mother-baby cohort
Mother-baby pairs with babies eligible for inclusion if they are born at 34 weeks gestational age and above, used as a validation cohort for the model.
Interventions
See above; multiple factors to be collected broadly grouped into maternal medical, obstetric, and sociodemographic/lifestyle factors.
Eligibility Criteria
The study populations will be recruited from Kawempe National Referral Hospital in Kampala, Uganda and Sally Mugabe Central Hospital in Harare, Zimbabwe.
You may qualify if:
- Neonates born at one of the study sites
- Neonates born at ≥34 weeks gestational age, defined by:
- Ultrasound scan, where participant has had an ultrasound scan during routine antenatal care
- If no ultrasound scan has been done, according to last menstrual period date, according to mother
You may not qualify if:
- Neonates born at \<34 weeks gestational age, due to their higher background risk of sepsis, and automatic admission to the neonatal unit with antibiotic administration
- Neonates with congenital abnormalities or syndromes associated with increased susceptibility to infection will be excluded (e.g. gastroschisis).
- Neonates whose mothers are unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St George's, University of Londonlead
- MU-JHU CAREcollaborator
- Biomedical Research and Training Institute, Zimbabwecollaborator
Study Sites (2)
Makerere University, John Hopkins University
Kawempe, Uganda
St George's, University of London
London, SW17 0RE, United Kingdom
Biospecimen
Dried blood spots will be retained for any samples where there is leftover sample
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2024
First Posted
May 13, 2024
Study Start
April 11, 2024
Primary Completion
December 31, 2024
Study Completion
March 1, 2025
Last Updated
May 17, 2024
Record last verified: 2024-02